Literature DB >> 3289994

Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes.

D G Bruce1, D J Chisholm, L H Storlien, E W Kraegen.   

Abstract

Patients with non-insulin-dependent diabetes mellitus (NIDDM) have a deficiency in early prandial insulin secretion. To determine the contribution of this early deficiency to prandial hyperglycemia, exogenous intravenous insulin (1.8 U over 30 min) was delivered to eight NIDDM subjects in a profile designed to simulate the normal initial rise in insulin levels. The same dose of insulin was also administered 1) in the same profile but delayed by 30 min and 2) as a constant infusion over 180 min. Augmentation of the early insulin response caused a 33 +/- 4% reduction in the glycemic response to a mixed meal (P less than .005); the peak blood glucose increment above baseline was reduced by 1.4 mM (P less than .005) to an increment identical to nondiabetic subjects (3.3 +/- 0.3 vs. 3.2 +/- 0.2 mM), and blood glucose levels were still 0.9 mM lower after 180 min (P less than .05). In contrast, the delayed profile or constant infusion did not significantly alter the glycemic response to the meal. Early insulin augmentation resulted in elevated peripheral insulin levels initially (peak level 81 +/- 11 mU/L), but subsequent insulin and C-peptide levels were lower than in the control study (at 180 min after the meal, 22 +/- 5 vs. 33 +/- 8 mU/L, P less than .05, and 4.0 +/- 0.5 vs. 5.3 +/- 0.6 micrograms/L, P less than .02, respectively). Early insulin delivery caused free-fatty acid (FFA) levels to fall at a faster rate after the meal and also attenuated the initial rise in glucagon levels typical of NIDDM.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3289994     DOI: 10.2337/diab.37.6.736

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  40 in total

1.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

Authors:  N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

Review 2.  The major diabetes prevention trials.

Authors:  Jaakko Tuomilehto; Jaana Lindström
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 4.810

Review 3.  Diabetes mellitus.

Authors:  A B Johnson; R Taylor
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

Review 4.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis.

Authors:  C N Hales; D J Barker
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

5.  Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance.

Authors:  A Basu; A Alzaid; S Dinneen; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

6.  The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.

Authors:  J Batch; A Ma; D Bird; R Noble; B Charles; P Ravenscroft; D Cameron
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

7.  First-Phase Insulin and Amylin after Bariatric Surgery: A Prospective Randomized Trial on Patients with Insulin Resistance or Diabetes after Gastric Bypass or Sleeve Gastrectomy.

Authors:  Rahel Nussbaumer; Anne Christin Meyer-Gerspach; Ralph Peterli; Thomas Peters; Christoph Beglinger; Sonja Chiappetta; Juergen Drewe; Bettina Wölnerhanssen
Journal:  Obes Facts       Date:  2020-11-17       Impact factor: 3.942

8.  Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes.

Authors:  Christoph Kapitza; Eric Zijlstra; Lutz Heinemann; M Cristina Castelli; Gary Riley; Tim Heise
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

9.  Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes.

Authors:  Cees J Tack; Vladimir Christov; Bastiaan E de Galan; Karl-Michael Derwahl; Gerhard Klausmann; Terezie Pelikánová; Jindra Perusicová; Anders H Boss; Nikhil Amin; David Kramer; Richard Petrucci; Wen Yu
Journal:  J Diabetes Sci Technol       Date:  2008-01

10.  First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery.

Authors:  Serenella Salinari; Alessandro Bertuzzi; Simone Asnaghi; Caterina Guidone; Melania Manco; Geltrude Mingrone
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.